betaxolol has been researched along with Extravascular Hemolysis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, H | 3 |
| Han, X | 1 |
| Li, H | 1 |
| Tao, Q | 1 |
| Hu, J | 1 |
| Liu, S | 1 |
| Zhou, J | 1 |
| Li, W | 1 |
| Yang, F | 1 |
| Ping, Q | 1 |
| Wei, S | 1 |
| Lin, H | 1 |
| Hou, D | 1 |
| Aoyagi, S | 1 |
| Fukunaga, S | 1 |
| Tayama, E | 1 |
| Nakamura, E | 1 |
| Egawa, N | 1 |
| Hosokawa, Y | 1 |
2 other studies available for betaxolol and Extravascular Hemolysis
| Article | Year |
|---|---|
Wettability and contact angle affect precorneal retention and pharmacodynamic behavior of microspheres.
Topics: Animals; Bentonite; Betaxolol; Cell Survival; Chemistry, Pharmaceutical; Delayed-Action Preparations | 2021 |
Benefits of a beta-blocker for intractable hemolysis due to paraprosthetic leakage.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Anemia, Hemolytic; Aspartate Aminotransferases; B | 2007 |